Whole Body MRI in Oncology
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
1,000 participants
Oct 26, 2023
OBSERVATIONAL
Conditions
Summary
Multicenter, observational, prospective, study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.
Eligibility
Inclusion Criteria4
- Patients candidate to WB-MRI according to clinical practice belonging to the study groups listed above.
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged ≥ 18 years.
- Life expectancy greater than 3 months.
Exclusion Criteria2
- Patients with MRI-unsafe prostheses and devices.
- Patients whose tests are of suboptimal quality, or whose test has been suspended, or is incomplete.
Interventions
This is a non-pharmacological, observational, prospective, study. Each patient will undergo quantitative WB-MRI as per clinical routine. WB-MRI may be performed: * at staging * at follow-up Disease progression is defined by clinicians taking into account all imaging modalities and clinicolaboratorial data available for the patients.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06895291